5347-19-3Relevant academic research and scientific papers
Organic compounds for organic electroluminescent materials
-
Paragraph 0048; 0049; 0050; 0051, (2017/10/13)
The invention discloses organic compounds for organic electroluminescent materials of which the structure is disclosed as General Formula (I), wherein A is C or N; and R1, R2 and R3 are respectively and separately selected from C1-C18 alkyls, substituted
SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS
-
Page 128-131, (2010/02/06)
The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b), enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R4, R5, and R7 are as defined herein. The invention further includes a method of CCR5-mediated
2-AMINOCARBONYL-QUINOLINE COMPOUNDS AS PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS
-
Page 42, (2010/02/07)
Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.
Platelet adenosine diphosphate receptor antagonists
-
, (2008/06/13)
Compounds of the following formula (I): where a, b, R1, R2, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, met
